A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy
Eiman Ibrahim(Yale University), Barbara E. Ehrlich(Yale University), Saira Munshani(Yale University), Richard J. Nowak(Yale University), Ilaria Domenicano(Yale University), Rozalyn L. Rodwin(Yale University), Maryam B. Lustberg(Yale Cancer Center), Lajos Pusztai(Yale University)
Cited by 14
Related Papers
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
|Journal of Clinical Oncology|2007|1.6k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830